- Home
- PCVX vs REG Comparison
PCVX vs REG Comparison
Compare PCVX & REG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCVX
- REG
- Stock Information
- Founded
- PCVX 2013
- REG 1963
- Country
- PCVX United States
- REG United States
- Employees
- PCVX N/A
- REG N/A
- Industry
- PCVX Biotechnology: Pharmaceutical Preparations
- REG Real Estate Investment Trusts
- Sector
- PCVX Health Care
- REG Real Estate
- Exchange
- PCVX Nasdaq
- REG Nasdaq
- Market Cap
- PCVX 13.2B
- REG 13.4B
- IPO Year
- PCVX 2020
- REG 1993
- Fundamental
- Price
- PCVX $85.30
- REG $71.22
- Analyst Decision
- PCVX Strong Buy
- REG Buy
- Analyst Count
- PCVX 9
- REG 13
- Target Price
- PCVX $149.38
- REG $77.54
- AVG Volume (30 Days)
- PCVX 1.2M
- REG 1.1M
- Earning Date
- PCVX 02-25-2025
- REG 02-06-2025
- Dividend Yield
- PCVX N/A
- REG 3.96%
- EPS Growth
- PCVX N/A
- REG 0.21
- EPS
- PCVX N/A
- REG 2.12
- Revenue
- PCVX N/A
- REG $1,489,813,000.00
- Revenue This Year
- PCVX N/A
- REG N/A
- Revenue Next Year
- PCVX N/A
- REG $3.78
- P/E Ratio
- PCVX N/A
- REG $33.53
- Revenue Growth
- PCVX N/A
- REG 13.47
- 52 Week Low
- PCVX $58.10
- REG $56.51
- 52 Week High
- PCVX $121.06
- REG $76.53
- Technical
- Relative Strength Index (RSI)
- PCVX 48.31
- REG 44.00
- Support Level
- PCVX $77.52
- REG $68.44
- Resistance Level
- PCVX $89.65
- REG $72.24
- Average True Range (ATR)
- PCVX 3.95
- REG 1.35
- MACD
- PCVX 0.77
- REG -0.07
- Stochastic Oscillator
- PCVX 62.04
- REG 43.17
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.
About REG Regency Centers Corporation
Regency Centers is one of the largest shopping center-focused retail REITs. The company's portfolio includes an interest in 483 properties, which includes over 57 million square feet of retail space following the completion of the Urstadt Biddle acquisition in August 2023. The portfolio is geographically diversified with 22 regional offices and no single market representing more than 12% of total company net operating income. Regency's retail portfolio is primarily composed of grocery-anchored centers, with 80% of properties featuring a grocery anchor and grocery stores representing 20% of annual base rent.